S&P 500   4,205.45
DOW   33,093.34
QQQ   348.40
China's 1st domestically made passenger plane completes maiden commercial flight
[BREAKING] New "Living Software" to Revolutionize Warfare (Ad)
In Nigeria’s hard-hit north, families seek justice as armed groups seek control
Biden and McCarthy reach a final deal to avoid US default and now must sell it to Congress
15 A.I. Trading Opportunities a Day (Ad)
EgyptAir flight from Cairo blows tire during landing in Saudi Arabia
Russia launched 'largest drone attack' on Ukrainian capital before Kyiv Day; 1 killed
Avoid the upcoming bloodbath (Ad)
'Succession' fans brace for series finale of Emmy-winning hit drama
Turkey's Erdogan wins another term as president, extends rule into 3rd decade
S&P 500   4,205.45
DOW   33,093.34
QQQ   348.40
China's 1st domestically made passenger plane completes maiden commercial flight
[BREAKING] New "Living Software" to Revolutionize Warfare (Ad)
In Nigeria’s hard-hit north, families seek justice as armed groups seek control
Biden and McCarthy reach a final deal to avoid US default and now must sell it to Congress
15 A.I. Trading Opportunities a Day (Ad)
EgyptAir flight from Cairo blows tire during landing in Saudi Arabia
Russia launched 'largest drone attack' on Ukrainian capital before Kyiv Day; 1 killed
Avoid the upcoming bloodbath (Ad)
'Succession' fans brace for series finale of Emmy-winning hit drama
Turkey's Erdogan wins another term as president, extends rule into 3rd decade
S&P 500   4,205.45
DOW   33,093.34
QQQ   348.40
China's 1st domestically made passenger plane completes maiden commercial flight
[BREAKING] New "Living Software" to Revolutionize Warfare (Ad)
In Nigeria’s hard-hit north, families seek justice as armed groups seek control
Biden and McCarthy reach a final deal to avoid US default and now must sell it to Congress
15 A.I. Trading Opportunities a Day (Ad)
EgyptAir flight from Cairo blows tire during landing in Saudi Arabia
Russia launched 'largest drone attack' on Ukrainian capital before Kyiv Day; 1 killed
Avoid the upcoming bloodbath (Ad)
'Succession' fans brace for series finale of Emmy-winning hit drama
Turkey's Erdogan wins another term as president, extends rule into 3rd decade
S&P 500   4,205.45
DOW   33,093.34
QQQ   348.40
China's 1st domestically made passenger plane completes maiden commercial flight
[BREAKING] New "Living Software" to Revolutionize Warfare (Ad)
In Nigeria’s hard-hit north, families seek justice as armed groups seek control
Biden and McCarthy reach a final deal to avoid US default and now must sell it to Congress
15 A.I. Trading Opportunities a Day (Ad)
EgyptAir flight from Cairo blows tire during landing in Saudi Arabia
Russia launched 'largest drone attack' on Ukrainian capital before Kyiv Day; 1 killed
Avoid the upcoming bloodbath (Ad)
'Succession' fans brace for series finale of Emmy-winning hit drama
Turkey's Erdogan wins another term as president, extends rule into 3rd decade

DICE Therapeutics (DICE) News Today

$32.81
-0.34 (-1.03%)
(As of 05/26/2023 ET)
Compare
Today's Range
$32.14
$33.69
50-Day Range
$25.86
$38.24
52-Week Range
$12.64
$45.99
Volume
212,713 shs
Average Volume
452,437 shs
Market Capitalization
$1.57 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$62.60
Get DICE Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for DICE and its competitors with MarketBeat's FREE daily newsletter.



DICE Media Mentions By Week

DICE Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

DICE
News Sentiment

0.66

0.75

Average
Medical
News Sentiment

DICE News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

DICE Articles
This Week

16

3

DICE Articles
Average Week

SourceHeadline
marketbeat.com logoAigen Investment Management LP Makes New Investment in DICE Therapeutics, Inc. (NASDAQ:DICE)
marketbeat.com - May 26 at 7:29 AM
MarketBeat logoDICE Therapeutics (NASDAQ:DICE) Now Covered by Wells Fargo & Company
americanbankingnews.com - May 26 at 3:58 AM
msn.com logoWells Fargo Initiates Coverage of DICE Therapeutics (DICE) with Equal-Weight Recommendation
msn.com - May 25 at 1:18 AM
msn.com logoDICE Therapeutics equalweight at Wells Fargo on lack of catalysts
msn.com - May 24 at 3:16 PM
markets.businessinsider.com logoH.C. Wainwright Sticks to Its Hold Rating for Sana Biotechnology (SANA)
markets.businessinsider.com - May 24 at 10:16 AM
MarketBeat logoDICE Therapeutics (NASDAQ:DICE) Shares Gap Up to $32.66
americanbankingnews.com - May 24 at 6:30 AM
marketbeat.com logoArizona State Retirement System Buys New Shares in DICE Therapeutics, Inc. (NASDAQ:DICE)
marketbeat.com - May 24 at 4:33 AM
proactiveinvestors.com logoDICE Therapeutics psoriasis treatment has blockbuster potential, analysts say
proactiveinvestors.com - May 23 at 7:17 PM
MarketBeat logoDICE Therapeutics (NASDAQ:DICE) Receives New Coverage from Analysts at Canaccord Genuity Group
americanbankingnews.com - May 23 at 3:00 AM
msn.com logoCanaccord Genuity Initiates Coverage of DICE Therapeutics (DICE) with Buy Recommendation
msn.com - May 23 at 12:41 AM
markets.businessinsider.com logoH.C. Wainwright Sticks to Their Buy Rating for Gracell Biotechnologies (GRCL)
markets.businessinsider.com - May 22 at 2:39 PM
marketbeat.com logoState Board of Administration of Florida Retirement System Reduces Stake in DICE Therapeutics, Inc. (NASDAQ:DICE)
marketbeat.com - May 22 at 4:54 AM
MarketBeat logoEquities Analysts Issue Forecasts for DICE Therapeutics, Inc.'s FY2023 Earnings (NASDAQ:DICE)
americanbankingnews.com - May 19 at 3:36 AM
markets.businessinsider.com logoH.C. Wainwright Sticks to Its Buy Rating for MiNK Therapeutics (INKT)
markets.businessinsider.com - May 18 at 12:35 PM
MarketBeat logoAnalysts Set DICE Therapeutics, Inc. (NASDAQ:DICE) Price Target at $64.63
americanbankingnews.com - May 18 at 2:58 AM
marketbeat.com logoEquities Analysts Set Expectations for DICE Therapeutics, Inc.'s FY2023 Earnings (NASDAQ:DICE)
marketbeat.com - May 17 at 7:26 AM
markets.businessinsider.com logoTrevi Therapeutics (TRVI) Receives a Rating Update from a Top Analyst
markets.businessinsider.com - May 15 at 7:05 AM
markets.businessinsider.com logoDice Therapeutics (DICE) Receives a Rating Update from a Top Analyst
markets.businessinsider.com - May 15 at 7:05 AM
marketbeat.com logoDICE Therapeutics, Inc. (NASDAQ:DICE) Receives Consensus Recommendation of "Buy" from Analysts
marketbeat.com - May 15 at 1:15 AM
msn.com logoHC Wainwright & Co. Reiterates DICE Therapeutics (DICE) Buy Recommendation
msn.com - May 12 at 11:47 PM
finanznachrichten.de logoDICE Therapeutics, Inc.: DICE Therapeutics Reports First Quarter 2023 Financial Results and Recent Highlights
finanznachrichten.de - May 12 at 8:45 AM
markets.businessinsider.com logoH.C. Wainwright Remains a Buy on Dice Therapeutics (DICE)
markets.businessinsider.com - May 12 at 8:45 AM
MarketBeat logoDICE Therapeutics, Inc. (NASDAQ:DICE) Director Sells $3,238,575.47 in Stock
americanbankingnews.com - May 12 at 4:38 AM
msn.com logoRecap: DICE Therapeutics Q1 Earnings
msn.com - May 11 at 8:39 PM
seekingalpha.com logoDICE Therapeutics GAAP EPS of -$0.54
seekingalpha.com - May 11 at 8:39 PM
finance.yahoo.com logoDICE Therapeutics Reports First Quarter 2023 Financial Results and Recent Highlights
finance.yahoo.com - May 11 at 8:39 PM
benzinga.com logoDICE Therapeutics Board Member Trades Company's Stock
benzinga.com - May 10 at 3:11 PM
marketbeat.com logoTD Asset Management Inc Boosts Position in DICE Therapeutics, Inc. (NASDAQ:DICE)
marketbeat.com - May 9 at 5:25 AM
msn.com logoDICE Therapeutics: Worth A Roll At The Right Price
msn.com - May 8 at 10:42 AM
MarketBeat logoInsider Selling: DICE Therapeutics, Inc. (NASDAQ:DICE) CMO Sells $365,400.00 in Stock
americanbankingnews.com - May 8 at 6:06 AM
MarketBeat logoInsider Selling: DICE Therapeutics, Inc. (NASDAQ:DICE) CFO Sells $685,312.50 in Stock
americanbankingnews.com - May 8 at 5:32 AM
MarketBeat logoDICE Therapeutics, Inc. (NASDAQ:DICE) CEO Sells $499,977.00 in Stock
americanbankingnews.com - May 8 at 5:32 AM
marketbeat.com logoZurcher Kantonalbank Zurich Cantonalbank Takes Position in DICE Therapeutics, Inc. (NASDAQ:DICE)
marketbeat.com - May 8 at 4:39 AM
marketbeat.com logoDICE Therapeutics, Inc. (NASDAQ:DICE) CMO Sells $365,400.00 in Stock
marketbeat.com - May 5 at 5:52 PM
marketbeat.com logoFox Run Management L.L.C. Takes $309,000 Position in DICE Therapeutics, Inc. (NASDAQ:DICE)
marketbeat.com - May 5 at 7:04 AM
marketbeat.com logoSG Americas Securities LLC Makes New $518,000 Investment in DICE Therapeutics, Inc. (NASDAQ:DICE)
marketbeat.com - May 4 at 5:02 AM
finance.yahoo.com logoDICE Therapeutics to Participate in the Bank of America Securities 2023 Healthcare Conference
finance.yahoo.com - May 3 at 8:34 PM
markets.businessinsider.com logoDice Therapeutics (DICE) Gets a Buy from H.C. Wainwright
markets.businessinsider.com - April 25 at 2:08 PM
marketbeat.com logo5,000 Shares in DICE Therapeutics, Inc. (NASDAQ:DICE) Purchased by DekaBank Deutsche Girozentrale
marketbeat.com - April 25 at 4:47 AM
MarketBeat logoDICE Therapeutics, Inc. (NASDAQ:DICE) Receives Average Rating of "Buy" from Analysts
americanbankingnews.com - April 25 at 2:12 AM
insidermonkey.com logoTop 5 Stocks Activist Investors Are Targeting
insidermonkey.com - April 21 at 4:26 PM
MarketBeat logoDICE Therapeutics, Inc. (NASDAQ:DICE) Insider John R. Jacobsen Sells 16,392 Shares
americanbankingnews.com - April 20 at 6:32 AM
marketbeat.com logoDICE Therapeutics, Inc. (NASDAQ:DICE) Given Average Recommendation of "Buy" by Analysts
marketbeat.com - April 20 at 4:44 AM
MarketBeat logoJohn R. Jacobsen Sells 773 Shares of DICE Therapeutics, Inc. (NASDAQ:DICE) Stock
americanbankingnews.com - April 6 at 6:06 AM
marketbeat.com logoDICE Therapeutics, Inc. (NASDAQ:DICE) Short Interest Up 13.2% in March
marketbeat.com - April 3 at 2:42 AM
MarketBeat logoInsider Buying: DICE Therapeutics, Inc. (NASDAQ:DICE) Director Buys $1,949,921.22 in Stock
americanbankingnews.com - April 2 at 4:52 AM
MarketBeat logoDICE Therapeutics (NASDAQ:DICE) Now Covered by Analysts at Needham & Company LLC
americanbankingnews.com - April 1 at 9:34 AM
MarketBeat logoJohn R. Jacobsen Sells 500 Shares of DICE Therapeutics, Inc. (NASDAQ:DICE) Stock
americanbankingnews.com - April 1 at 8:08 AM
marketbeat.com logoDICE Therapeutics (NASDAQ:DICE) Coverage Initiated at Needham & Company LLC
marketbeat.com - March 31 at 7:45 AM
MarketBeat logoDICE Therapeutics, Inc. (NASDAQ:DICE) Receives $65.86 Consensus Price Target from Analysts
americanbankingnews.com - March 31 at 2:58 AM
Get DICE Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for DICE and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:DICE) was last updated on 5/28/2023 by MarketBeat.com Staff

My Account -